Paternal Age and Fetal Aneuploidy

Active, not recruitingOBSERVATIONAL
Enrollment

30,000

Participants

Timeline

Start Date

July 31, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

July 31, 2025

Conditions
Trisomy 21
Interventions
DIAGNOSTIC_TEST

Optimo prenatal screening test

Prenatal screening test done between weeks 11 and 13 of pregnancy to detect conditions such as trisomy 13, 18 and 21

Trial Locations (1)

H4P 2S4

Clinique Ovo, Montreal

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Clinique Ovo

INDUSTRY

NCT05981521 - Paternal Age and Fetal Aneuploidy | Biotech Hunter | Biotech Hunter